1.
IA-2 antibodies : a sensitive marker of IDDM with clinical onset in childhood and adolescence
by SAVOLA, K
Diabetologia, 1998, Vol.41 (4), p.424-429

2.
Epidemiology of childhood diabetes mellitus in Finland-background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus
by TUOMILEHTO, J
Diabetologia, 1992, Vol.35 (1), p.70-76

3.
Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes
by SABBAH, E
The journal of clinical endocrinology and metabolism, 1996, Vol.81 (7), p.2455-2459

4.
Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual β cell function
by KOMULAINEN, J
Archives of disease in childhood, 1996, Vol.75 (5), p.410-415

5.
Soluble adhesion molecules in preclinical type 1 Diabetes
by TOIVONEN, Anna
Pediatric research, 2001, Vol.49 (1), p.24-29

6.
Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella...
by HYÖTY, H
Diabetologia, 1993, Vol.36 (12), p.1303-1308

7.
Natural history of preclinical IDDM in high risk siblings
by KNIP, M
Diabetologia, 1994, Vol.37 (4), p.388-393

8.
Diet, cows' milk protein antibodies and the risk of IDDM in Finnish children
by VIRTANEN, S. M
Diabetologia, 1994, Vol.37 (4), p.381-387

9.
Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses
by RØDER, M. E
The journal of clinical endocrinology and metabolism, 1994, Vol.79 (6), p.1570-1575

10.
Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM : a prospective study
by HILTUNEN, M
Diabetologia, 1995, Vol.38 (6), p.705-710

11.
HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus : molecular analysis of the HLA-DQ locus
by TIENARI, P. J
Diabetologia, 1992, Vol.35 (3), p.254-260

12.
In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk
by METCALFE, K. A
Diabetologia, 1995, Vol.38 (10), p.1223-1229
